DRAXIMAGE MDP-25 DIN 02329239
Health Canada record
| Active ingredient(s) | MEDRONIC ACID 25 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | V09BA02 TECHNETIUM (99m Tc) MEDRONIC ACID |
| Original market date | 29-Sep-2005 |
| Current status date | 23-Aug-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jubilant Draximage Inc. dba Jubilant Radiopharma — licence 101869, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MEDRONIC ACID
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02329409 | DRAXIMAGE MDP | JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA | Powder For Solution | MEDRONIC ACID 10 MG | Marketed |
| 02485834 | STANNOUS MDP KIT | CALGARY RADIOPHARMACEUTICAL CENTRE / ALBERTA HEALTH SERVICES | Solution; Kit | MEDRONIC ACID 15 MG | Marketed |
| 02329069 | MDP MULTIDOSE UTILIPAK | GE HEALTHCARE CANADA INC | Powder For Solution | MEDRONIC ACID 30 MG; STANNOUS CHLORIDE 0.51 MG | Cancelled Pre Market |
| 02482304 | MDP-10 | EDMONTON RADIOPHARMACEUTICAL CENTRE (ALBERTA HEALTH SERVICES) | Powder For Solution; Kit | MEDRONIC ACID 10 MG | Cancelled Pre Market |
| 02482312 | MDP-21 | EDMONTON RADIOPHARMACEUTICAL CENTRE (ALBERTA HEALTH SERVICES) | Kit; Powder For Solution | MEDRONIC ACID 20 MG | Cancelled Pre Market |
| 02329859 | MDP-BRACCO | BRACCO IMAGING CANADA | Powder For Solution | MEDRONIC ACID 20 MG | Cancelled Pre Market |